Needham: 'we believe that IMDX is making good progress towards its GraftAssureDx submissions' Jan 5, 2026 12:27PM
Insight Molecular Diagnostics Inc. (IMDX) PT Raised to $9 at Needham Nov 11, 2025 04:51AM
Needham Reiterates Buy Rating on Insight Molecular Diagnostics Inc. (IMDX) Aug 12, 2025 06:41AM
iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference Aug 4, 2025 04:05PM